Table 2.
Distribution of risk in simulated populations based on the combined multiplicative effect of all variants discovered in genome-wide association studies
Cancer type | Variants considered | Risk in percentile of simulated risk* |
RR in upper vs lower decile (95% CI) | RR in upper vs lower quartile (95% CI) | ||||
10th | 25th | 50th | 75th | 90th | ||||
Colorectal | 10 | 66.4 | 78.3 | 95.6 | 113.3 | 139.6 | 2.75 (2.41 to 3.14) | 2.10 (1.91 to 2.31) |
Prostate | 26 | 43.2 | 58.7 | 84.8 | 123.1 | 174.4 | 6.85 (6.02 to 7.79) | 4.08 (3.67 to 4.53) |
Testicular | 3 | 39.8 | 54.5 | 101.4 | 138.9 | 152 | 7.99 (7.06 to 9.03) | 4.19 (3.89 to 4.52) |
Thyroid | 2 | 58.9 | 58.9 | 80.8 | 131.8 | 141.4 | 4.45 (3.96 to 5.01) | 4.09 (3.75 to 4.46) |
Risks are shown standardized against the mean simulated risk in the population (mean = 100). CI = confidence interval; RR = relative risk.